MC Stock Analysis: Moelis | NYSE
Capital Markets | NYSE, USA | Market Cap: 4.261m USD | 12M Return: -12.5% | US60786M1053 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 53.8M
Qual. Beats: 0
Rev. Trend: 97.5%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Moelis & Company (NYSE: MC) is a global investment banking advisory firm headquartered in New York, founded in 2007 and publicly traded since its 2014 IPO. The company provides a range of corporate finance advisory services, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other strategic and capital structure advisory work, serving clients such as public multinational corporations, middle market private companies, financial sponsors, entrepreneurs, governments, and sovereign wealth funds. Operating across North and South America, Europe, the Middle East, Asia, and Australia, Moelis operates within the Investment Banking & Brokerage sub-industry, a sector that generates revenue primarily through fee-based advisory engagements rather than principal trading, and that tends to experience earnings volatility tied to global M&A and capital markets activity.
- M&A deal volume rebounded in 2024 boosting advisory revenue
- Restructuring mandates surge as high rate environment pressures corporates
- Hiring senior bankers expands coverage and drives league table rankings
| Net Income: 228.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.30 > 0.02 and ΔFCF/TA -1.10 > 1.0 |
| NWC/Revenue: -7.95% < 20% (prev -14.62%; Δ 6.67% < -1%) |
| CFO/TA 0.35 > 3% & CFO 490.5m > Net Income 228.3m |
| Net Debt (55.0m) to EBITDA (313.6m): 0.18 < 3 |
| Current Ratio: 0.69 > 1.5 & < 3 |
| Outstanding Shares: last quarter (79.4m) vs 12m ago 0.98% < -2% |
| Gross Margin: 69.91% > 18% (prev 32.72%; Δ 37.19% > 0.5%) |
| Asset Turnover: 114.4% > 50% (prev 103.1%; Δ 11.32% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: -0.09 (Total Current Assets 274.6m - Total Current Liabilities 399.8m) / Total Assets 1.41b |
| B: -0.58 (Retained Earnings -822.4m / Total Assets 1.41b) |
| C: 0.22 (EBIT TTM 299.6m / Avg Total Assets 1.38b) |
| D: 0.66 (Book Value of Equity 505.8m / Total Liabilities 766.6m) |
| Altman-Z'' = -0.33 = B |
| DSRI: 0.96 (Receivables 111.9m/102.8m, Revenue 1.57b/1.38b) |
| GMI: 0.47 (GM 32.72% / 69.91%) |
| AQI: 1.13 (AQ_t 0.65 / AQ_t-1 0.58) |
| SGI: 1.14 (Revenue 1.57b / 1.38b) |
| TATA: -0.19 (NI 228.3m - CFO 490.5m) / TA 1.41b) |
| Beneish M = -3.38 (Cap -4..+1) = AA |
As of October 08, 2026, the stock is trading at USD 56.15 with a total of 1,443,865 shares traded. Over the past week, the price has changed by -2.38%, over one month by -18.35%, over three months by -18.81% and over the past year by -12.52%.
Current recommended Stop Loss: 53.30 (which is 5.1% or 1.4 ATR below the current price).
Moelis has received a consensus analysts rating of 2.63. Therefore, it is recommended to hold MC.
- StrongBuy: 0
- Buy: 1
- Hold: 5
- Sell: 0
- StrongSell: 2
| Analysts Target Price | 72 | 28.2% |
P/E Trailing = 20.0418
P/E Forward = 13.369
P/S = 2.7072
P/B = 8.5211
P/EG = 1.97
Revenue TTM = 1.57b USD
EBIT TTM = 299.6m USD
EBITDA TTM = 313.6m USD
Long Term Debt = 247.4m USD (estimated: total debt 262.8m - short term 15.3m)
Short Term Debt = 15.3m USD (from shortTermDebt, last quarter)
Debt = 262.8m USD (from shortLongTermDebtTotal, last quarter) (leases 262.8m already included)
Net Debt = 55.0m USD (calculated: Debt 262.8m - CCE 207.7m)
Enterprise Value = 4.32b USD (4.26b + Debt 262.8m - CCE 207.7m)
Interest Coverage Ratio = unknown (Ebit TTM 299.6m / Interest Expense TTM 0.0)
EV/FCF = 10.16x (Enterprise Value 4.32b / FCF TTM 424.6m)
FCF Yield = 9.84% (FCF TTM 424.6m / Enterprise Value 4.32b)
FCF Margin = 26.98% (FCF TTM 424.6m / Revenue TTM 1.57b)
Net Margin = 14.50% (Net Income TTM 228.3m / Revenue TTM 1.57b)
Gross Margin = 69.91% ((Revenue TTM 1.57b - Cost of Revenue TTM 473.6m) / Revenue TTM)
Gross Margin QoQ = none% (prev 34.20%)
Tobins Q-Ratio = 3.07 (Enterprise Value 4.32b / Total Assets 1.41b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 262.8m)
Taxrate = 24.94% (85.2m / 341.7m)
NOPAT = 224.9m (EBIT 299.6m * (1 - 24.94%))
Current Ratio = 0.64 (Total Current Assets 274.6m / Total Current Liabilities 431.1m)
Debt / Equity = 0.52 (Debt 262.8m / totalStockholderEquity, last quarter 505.8m)
Debt / EBITDA = 0.18 (Net Debt 55.0m / EBITDA 313.6m)
Debt / FCF = 0.13 (Net Debt 55.0m / FCF TTM 424.6m)
Total Stockholder Equity = 524.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 16.60% (Net Income 228.3m / Total Assets 1.41b)
RoE = 43.55% (Net Income TTM 228.3m / Total Stockholder Equity 524.1m)
RoCE = 38.83% (EBIT 299.6m / Capital Employed (Equity 524.1m + L.T.Debt 247.4m))
RoIC = 16.89% (NOPAT 224.9m / Invested Capital 1.33b)
WACC = 11.25% (E(4.26b)/V(4.52b) * Re(11.94%) + D(262.8m)/V(4.52b) * Rd(0.0%) * (1-Tc(0.25)))
Discount Rate = 11.94% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 94.05 | Cagr: 2.51%
[DCF] Terminal Value 66.19% ; FCFF base≈422.6m ; Y1≈428.6m ; Y5≈463.2m
[DCF] Fair Price = 64.22 (EV 4.81b - Net Debt 55.0m = Equity 4.76b / Shares 74.1m; r=11.25% [WACC]; 5y FCF grow 1.21% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.04 | # QB: 0
Revenue Correlation: 97.46 | Revenue CAGR: 30.52% | SUE: 0.61 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.76 | Chg30d=-3.48% | Revisions=-50% | Analysts=11
EPS current Year (2026-12-31): EPS=3.08 | Chg30d=-0.14% | Revisions=-22% | GrowthEPS=+2.8% | GrowthRev=+13.3%
EPS next Year (2027-12-31): EPS=3.92 | Chg30d=+0.27% | Revisions=-10% | GrowthEPS=+27.5% | GrowthRev=+17.4%
[Analyst] Revisions Ratio: -35% (up=6, down=14)